Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, X-Linked

Explore clinical trials studying Genetic Diseases, X-Linked. Study availability and eligibility vary by location and protocol.

1,244 public trials 227 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, X-Linked trial results

Completed

Natural History of Rett Syndrome & Related Disorders

NCT02738281

Conditions
CDKL5 Disorder, CDKL5 deficiency disorder, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCSF Oakland Benioff Children's Hospital Oakland, California, United States
  • University of California San Diego San Diego, California, United States
  • University of Colorado Denver Denver, Colorado, United States
View all 14 locations
View Trial Details
Completed

Replagal Enzyme Replacement Therapy for Children With Fabry Disease

NCT00084084

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations
  • Tucson Access Center of Arizona Kidney Disease Hypertension Center Tucson, Arizona, United States
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Children's Physician Group Palm Beach Gardens, Florida, United States
  • Christus St. Patrick Hospital Lake Charles, Louisiana, United States
View all 14 locations
View Trial Details
Completed

This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes.

NCT01304277

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of Alberta Hospital Edmonton, Alberta, Canada
  • Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
  • The Hospital for Sick Children Toronto, Ontario, Canada
  • INC Research Toronto, Ontario, Canada
View Trial Details
Completed

A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®

NCT00920647

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +23 more
Locations
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Birmingham Children's Hospital NHS Foundation Trust Birmingham, United Kingdom
View Trial Details
Completed

Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®

NCT00937794

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +17 more
Locations
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Birmingham Children's Hospital Birmingham, United Kingdom
View Trial Details
Completed

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

NCT02055118

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +23 more
Locations
  • Children's Hospital and Research Center at Oakland Oakland, California, United States
  • Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Women's and Children's Hospital, 72 King William Road North Adelaide, Australia
View Trial Details

Related conditions